TWO SIGMA INVESTMENTS, LP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 71 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$82,280
-61.4%
31,525
-47.1%
0.00%
-100.0%
Q2 2023$213,368
-80.7%
59,600
-88.2%
0.00%
-66.7%
Q1 2023$1,103,636
+4.5%
506,255
+210.6%
0.00%
-25.0%
Q3 2022$1,056,000
-63.9%
163,015
-74.5%
0.00%
-60.0%
Q2 2022$2,929,000
-38.5%
639,557
+16.1%
0.01%
-28.6%
Q1 2022$4,766,000
-17.0%
550,956
+37.0%
0.01%
+16.7%
Q4 2021$5,742,000402,0970.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 781,292$2,039,1721.87%
GSA CAPITAL PARTNERS LLP 88,923$2320.02%
Glass Jacobson Investment Advisors llc 12,255$31,9860.02%
Rathbones Group PLC 289,803$756,3860.01%
N.E.W. Advisory Services LLC 12,960$33,8260.01%
Virtu Financial LLC 17,388$450.00%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$14,6870.00%
ALGERT GLOBAL LLC 14,680$380.00%
Close Asset Management Ltd 11,400$300.00%
Altshuler Shaham Ltd 12,847$33,4080.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders